Latest filing published 16 Jul 2024 for ZEVRA THERAPEUTICS, INC., €62k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +92.1%Entry US$6.59 · Close at T+365 US$12.66
- +38.9%Entry US$5.27 · Close at T+365 US$7.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas Anderson: trading record in brief
This profile gathers the share dealings of Thomas Anderson across 2 companies, led by Sage Therapeutics, Inc. and Zevra Therapeutics, Inc. We count 13 filings; the first trade dates from 23 July 2014 and the latest from 16 July 2024.
Both buying and selling appear: 3 purchases worth €188k, against 6 sales worth €1.3M. Sales outweigh purchases by €1.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 3 option exercises. 2024 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €62k.
Most recently, on 16 July 2024, the filings show an open-market purchase worth €62k in Zevra Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas Anderson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$6.806557.9% of flowCommon StockSEC:0001437749-24-022829:0Canonical exit: 14 Oct 2024 (T+90)
- 10,000 shares@ US$4.876442.1% of flowCommon StockSEC:0001437749-23-025312:0Canonical exit: 5 Dec 2023 (T+90)
- 1,900 shares@ US$8.922.6% of flowCommon StockSEC:0001562180-16-003843:0
- 346 shares@ US$48.992.6% of flowCommon StockSEC:0001562180-16-003843:1
- 10,000 shares@ US$8.9213.2% of flowCommon StockSEC:0001562180-16-003622:0
- 10,000 shares@ US$55.0081.6% of flowCommon StockSEC:0001562180-16-003622:1
- 3,480 shares@ US$67.66Common StockSEC:0001562180-15-000660:0
- 1,220 shares@ US$67.14Common StockSEC:0001562180-15-000660:1
- 1,300 shares@ US$65.34Common StockSEC:0001562180-15-000660:2
- 5,500 shares@ US$8.92Common StockSEC:0001562180-15-000467:0
- 4,300 shares@ US$79.95Common StockSEC:0001562180-15-000467:1
- 1,200 shares@ US$78.56Common StockSEC:0001562180-15-000467:2
- 6,000 shares@ US$18.00Common StockSEC:0001209191-14-048702:0Canonical exit: 21 Oct 2014 (T+90)
13 of 13 declarations
